Skip to main content
. 2024 Aug 7;33(11):3093–3105. doi: 10.1007/s11136-024-03748-3

Table 1.

Background characteristics of sample participants (N = 1947)

Mean (SD)
EQ-5D-5L
 EQ-5D index 0.46 (0.25)
 EQ-5D VAS Health 0-100 47.45 (18.79)
Age 32.20 (10.25)
PHQ-9 16.05 (5.51)
GAD-7 12.43 (4.75)
PHQ-ADS 28.49 (9.14)
Frequency (%)
Sex
 Female 1262 (64.88)
 Male 685 (35.18)
Married/cohabitant/in a relationship 799 (41.04)
Occupation status
 Working/studying 1056 (54.24)
 Sick leave 546 (28.04)
 Disability benefits 80 (4.11)
 WAA 265 (13.61)
Antidepressants 321 (16.49)
Anxiolytics 40 (2.05)
Pain medication 28 (1.44)
Hypnotics  25 (1.28)
Psychostimulants  77 (3.96)
Primary disorders
 F30 Depressive 741 (38.06)
 F40 Anxiety 481 (24.70)
 F60 Personality 194 (9.96)
 F90 Hyperkinetic 315 (16.18)
 Trauma-related 216 (11.09)
Comorbidity 630 (32.40)
Comorbid disorders
 F10 Substance use 14 (0.70)
 F30 Depressive 250 (12.84)
 F40 Anxiety 249 (12.79)
 F50 Eating 28 (1.43)
 F60 Personality 3 (0.15)
 F80 Development 19 (0.97)
 F90 Hyperkinetic 65 (3.34)
 Trauma-related 2 (0.10)

Note. VAS = Visual Analogue Scale. PHQ-9 = Patient Health Questionnaire 9. GAD-7 = Generalized Anxiety Disorder 7. PHQ-ADS = Patient Health Questionnaire Anxiety and Depression Scale. WAA = Work Assessment Allowance